Emugrobart

N/A

Report date: 2025/12/25 15:59:24

Base Information

Drug NameEmugrobart
Drug Alias NameRO-7204239GYM-329RG-6237RG-70240
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[14
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOverweightObesityDiabetes Mellitus, Type 2 +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A